Denali Therapeutics (DNLI) Gross Margin (2026)
Denali Therapeutics (DNLI) recorded Gross Margin of 98.92% in Q3 2026, up 1.50 percentage points from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Gross Margin (2026) Analysis & Trends
On a TTM basis, Denali Therapeutics' Gross Margin came in at 98.67% as of Sep 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 75.71% |
| 10 | Denali Therapeutics | 3.83 Bn | 743.92 Mn | 17.59 Mn | 98.92% |
API Access
Denali Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();